FLT1 c.64+4948C>T

Variant ID: 13-29063969-G-A

NM_002019.4(FLT1):c.64+4948C>T

This variant was identified in 3 publications

View GRCh38 version.




Publications:


An update on biomarkers of potential benefit with bevacizumab for breast cancer treatment: Do we make progress?

Chinese Journal Of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
Liang, Xu X; Li, Huiping H; Coussy, Florence F; Callens, Celine C; Lerebours, Florence F
Publication Date: 2019-08

Variant appearance in text: rs600640
PubMed Link: 31564802
Variant Present in the following documents:
  • Main text
  • cjcr-31-4-586.pdf
View BVdb publication page



A pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer.

Carcinogenesis
Slattery, Martha L ML; Wolff, Roger K RK; Lundgreen, Abbie A
Publication Date: 2015-01

Variant appearance in text: rs600640
PubMed Link: 25330801
Variant Present in the following documents:
  • Main text
View BVdb publication page



Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

Genomics Insights
Driss, A A; Asare, K O KO; Hibbert, J M JM; Gee, B E BE; Adamkiewicz, T V TV; Stiles, J K JK
Publication Date: 2009-07-30

Variant appearance in text: rs600640
PubMed Link: 20401335
Variant Present in the following documents:
  • Main text
  • gei-2-2009-023.pdf
View BVdb publication page